Named as a key player in 66 of our reports, across 33 regions and countries.
Our reports that name Balance as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Balance (number of shared markets).
Calm1 shared market
Elektra Health1 shared market
Evernow1 shared market
Gennev1 shared market
Headspace Inc.1 shared market
Insight Timer1 shared market
Maven Clinic1 shared market
Midi Health1 shared market
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
0 active studies led by Balance, of 4 in all
Source: ClinicalTrials.gov, Studies with Balance (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Balance leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Balance or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
The topics of the markets Balance is in.
Stories on the topics Balance works in.
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
About 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
Read